메뉴 건너뛰기




Volumn 55, Issue 12, 2014, Pages 2801-2807

Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: The FRALLE-93 pediatric protocol

Author keywords

Acute lymphoblastic leukemia; Adults; Chemotherapy protocol; Disease risk; Overall survival

Indexed keywords

ASPARAGINASE; CD20 ANTIGEN; CD34 ANTIGEN; CD79A ANTIGEN; COTRIMOXAZOLE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DNA NUCLEOTIDYLEXOTRANSFERASE; DOXORUBICIN; ETOPOSIDE; HYDROCORTISONE; MERCAPTOPURINE; METHOTREXATE; MYELOPEROXIDASE; PREDNISOLONE; TIOGUANINE; VINCRISTINE; VINDESINE; ANTINEOPLASTIC AGENT;

EID: 84919461554     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2014.894191     Document Type: Article
Times cited : (18)

References (18)
  • 1
    • 14644425248 scopus 로고    scopus 로고
    • Adolescents with acute lymphatic leukaemia achieve signif cantly better results when treated following Dutch paediatric oncology protocols than with adult protocols
    • de Bont JM, van der Holt B, Dekker AW, van et al. [Adolescents with acute lymphatic leukaemia achieve signif cantly better results when treated following Dutch paediatric oncology protocols than with adult protocols]. Ned Tijdschr Geneeskd 2005;149:400-406.
    • (2005) Ned Tijdschr Geneeskd , vol.149 , pp. 400-406
    • De Bont, J.M.1    Van Der Holt, B.2    Van, D.A.W.3
  • 2
    • 33749601315 scopus 로고    scopus 로고
    • Treatment outcome in young adults and children 10 years of age with acute lymphoblastic leukemia in Sweden: A comparison between a pediatric protocol and an adult protocol
    • Hallbook H, Gustafsson G, Smedmyr B, et al. Treatment outcome in young adults and children 10 years of age with acute lymphoblastic leukemia in Sweden: a comparison between a pediatric protocol and an adult protocol. Cancer 2006;107:1551-1561.
    • (2006) Cancer , vol.107 , pp. 1551-1561
    • Hallbook, H.1    Gustafsson, G.2    Smedmyr, B.3
  • 3
    • 33846908289 scopus 로고    scopus 로고
    • Adolescents with acute lymphoblastic leukaemia: Outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials
    • Ramanujachar R, Richards S, Hann I, et al. Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials. Pediatr Blood Cancer 2007;48:254-261.
    • (2007) Pediatr Blood Cancer , vol.48 , pp. 254-261
    • Ramanujachar, R.1    Richards, S.2    Hann, I.3
  • 4
    • 47849108085 scopus 로고    scopus 로고
    • What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
    • Stock W, La M, Sanford B, et al. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies. Blood 2008;112:1646-1654.
    • (2008) Blood , vol.112 , pp. 1646-1654
    • Stock, W.1    La Sanford M, B.2
  • 5
    • 77956408842 scopus 로고    scopus 로고
    • Outcomes for children and adolescents with cancer: Challenges for the twenty-first century
    • Smith MA, Seibel NL, Altekruse SF, et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 2010;28:2625-2634.
    • (2010) J Clin Oncol , vol.28 , pp. 2625-2634
    • Smith, M.A.1    Seibel, N.L.2    Altekruse, S.F.3
  • 6
    • 57649126380 scopus 로고    scopus 로고
    • Treatment of adult acute lymphoblastic leukemia
    • Gokbuget N, Hoelzer D. Treatment of adult acute lymphoblastic leukemia. Semin Hematol 2009;46:64-75.
    • (2009) Semin Hematol , vol.46 , pp. 64-75
    • Gokbuget, N.1    Hoelzer, D.2
  • 7
    • 0032572912 scopus 로고    scopus 로고
    • Acute lymphoblastic leukemia
    • Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998;339:605-615.
    • (1998) N Engl J Med , vol.339 , pp. 605-615
    • Pui, C.H.1    Evans, W.E.2
  • 8
    • 41349100708 scopus 로고    scopus 로고
    • In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less Effective than conventional consolidation/maintenance chemotherapy in all patients: F nal results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
    • Goldstone AH, Richards SM, Lazarus HM, et al. In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less Effective than conventional consolidation/maintenance chemotherapy in all patients: f nal results of the International ALL Trial (MRC UKALL XII/ECOG E2993). Blood 2008;111:1827-1833.
    • (2008) Blood , vol.111 , pp. 1827-1833
    • Goldstone, A.H.1    Richards, S.M.2    Lazarus, H.M.3
  • 9
    • 0037362950 scopus 로고    scopus 로고
    • Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials
    • Boissel N, Auclerc MF, Lheritier V, et al. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials. J Clin Oncol 2003;21:774-780.
    • (2003) J Clin Oncol , vol.21 , pp. 774-780
    • Boissel, N.1    Auclerc, M.F.2    Lheritier, V.3
  • 10
    • 80755153624 scopus 로고    scopus 로고
    • Intensif ed chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40
    • Rijneveld AW, van der Holt B, Daenen SM, et al. Intensif ed chemotherapy inspired by a pediatric regimen combined with allogeneic transplantation in adult patients with acute lymphoblastic leukemia up to the age of 40. Leukemia 2011; 25: 1697-1703.
    • (2011) Leukemia , vol.25 , pp. 1697-1703
    • Rijneveld, A.W.1    Van Der Holt, B.2    Daenen, S.M.3
  • 12
    • 42249091014 scopus 로고    scopus 로고
    • Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia
    • Flex E, Petrangeli V, Stella L, et al. Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia. J Exp Med 2008;205:751-758.
    • (2008) J Exp Med , vol.205 , pp. 751-758
    • Flex, E.1    Petrangeli, V.2    Stella, L.3
  • 13
    • 70449719091 scopus 로고    scopus 로고
    • IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: A GIMEMA AL WP report
    • Martinelli G, Iacobucci I, Storlazzi CT, et al. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report. J Clin Oncol 2009;27:5202-5207.
    • (2009) J Clin Oncol , vol.27 , pp. 5202-5207
    • Martinelli, G.1    Iacobucci, I.2    Storlazzi, C.T.3
  • 14
    • 84863785952 scopus 로고    scopus 로고
    • Newly diagnosed acute lymphoblastic leukemia in China (II): Prognosis related to genetic abnormalities in a series of 1091 cases
    • Mi JQ, Wang X, Yao Y, et al. Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases. Leukemia 2012; 26: 1507-1516.
    • (2012) Leukemia , vol.26 , pp. 1507-1516
    • Mi, J.Q.1    Wang, X.2    Yao, Y.3
  • 15
    • 84870604295 scopus 로고    scopus 로고
    • Has MRD monitoring superseded other prognostic factors in adult ALL?
    • Bruggemann M, Raf T, Kneba M. Has MRD monitoring superseded other prognostic factors in adult ALL? Blood 2012; 120: 4470-4481.
    • (2012) Blood , vol.120 , pp. 4470-4481
    • Bruggemann, M.1    Raf, T.2    Kneba, M.3
  • 16
    • 0034210549 scopus 로고    scopus 로고
    • Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group
    • Schrappe M, Reiter A, Ludwig WD, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood 2000; 95:3310-3322.
    • (2000) Blood , vol.95 , pp. 3310-3322
    • Schrappe, M.1    Reiter, A.2    Ludwig, W.D.3
  • 17
    • 47049093795 scopus 로고    scopus 로고
    • Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A Children's Oncology Group study
    • Borowitz MJ, Devidas M, Hunger SP, et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. Blood 2008; 111: 5477-5485.
    • (2008) Blood , vol.111 , pp. 5477-5485
    • Borowitz, M.J.1    Devidas, M.2    Hunger, S.P.3
  • 18
    • 60949101218 scopus 로고    scopus 로고
    • Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: The GRAALL-2003 study
    • Huguet F, Leguay T, Raf oux E, et al. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J Clin Oncol 2009;27:911-918.
    • (2009) J Clin Oncol , vol.27 , pp. 911-918
    • Huguet, F.1    Leguay, T.2    Rafoux, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.